JP2015508828A5 - - Google Patents

Download PDF

Info

Publication number
JP2015508828A5
JP2015508828A5 JP2014560091A JP2014560091A JP2015508828A5 JP 2015508828 A5 JP2015508828 A5 JP 2015508828A5 JP 2014560091 A JP2014560091 A JP 2014560091A JP 2014560091 A JP2014560091 A JP 2014560091A JP 2015508828 A5 JP2015508828 A5 JP 2015508828A5
Authority
JP
Japan
Prior art keywords
amino
pyridin
pyrimidin
optionally substituted
fluorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014560091A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015508828A (ja
JP6068515B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/028622 external-priority patent/WO2013130976A1/en
Publication of JP2015508828A publication Critical patent/JP2015508828A/ja
Publication of JP2015508828A5 publication Critical patent/JP2015508828A5/ja
Application granted granted Critical
Publication of JP6068515B2 publication Critical patent/JP6068515B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014560091A 2012-03-01 2013-03-01 セリン/トレオニンキナーゼ阻害剤 Active JP6068515B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261605523P 2012-03-01 2012-03-01
US61/605,523 2012-03-01
PCT/US2013/028622 WO2013130976A1 (en) 2012-03-01 2013-03-01 Serine/threonine kinase inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015179810A Division JP2016027053A (ja) 2012-03-01 2015-09-11 セリン/トレオニンキナーゼ阻害剤

Publications (3)

Publication Number Publication Date
JP2015508828A JP2015508828A (ja) 2015-03-23
JP2015508828A5 true JP2015508828A5 (https=) 2015-11-05
JP6068515B2 JP6068515B2 (ja) 2017-01-25

Family

ID=47892024

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014560091A Active JP6068515B2 (ja) 2012-03-01 2013-03-01 セリン/トレオニンキナーゼ阻害剤
JP2015179810A Withdrawn JP2016027053A (ja) 2012-03-01 2015-09-11 セリン/トレオニンキナーゼ阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015179810A Withdrawn JP2016027053A (ja) 2012-03-01 2015-09-11 セリン/トレオニンキナーゼ阻害剤

Country Status (36)

Country Link
US (4) US8697715B2 (https=)
EP (2) EP2820009B1 (https=)
JP (2) JP6068515B2 (https=)
KR (1) KR102093526B1 (https=)
CN (2) CN106349217B (https=)
AR (2) AR090220A1 (https=)
AU (1) AU2013225737B2 (https=)
BR (1) BR112014021634B1 (https=)
CA (1) CA2866086C (https=)
CL (1) CL2014002301A1 (https=)
CO (1) CO7081155A2 (https=)
CR (1) CR20140413A (https=)
CY (1) CY1120172T1 (https=)
DK (2) DK2820009T3 (https=)
ES (2) ES2857649T3 (https=)
HR (2) HRP20180591T1 (https=)
HU (2) HUE037423T2 (https=)
IL (2) IL234376A (https=)
LT (2) LT2820009T (https=)
MX (1) MX354675B (https=)
MY (1) MY191936A (https=)
NO (1) NO2945854T3 (https=)
NZ (1) NZ700314A (https=)
PE (1) PE20150666A1 (https=)
PH (3) PH12014501947B1 (https=)
PL (2) PL2820009T3 (https=)
PT (2) PT2820009T (https=)
RS (2) RS61500B1 (https=)
RU (1) RU2650501C2 (https=)
SG (1) SG11201405356QA (https=)
SI (2) SI2820009T1 (https=)
SM (1) SMT201800282T1 (https=)
TW (1) TWI589569B (https=)
UA (1) UA116774C2 (https=)
WO (1) WO2013130976A1 (https=)
ZA (2) ZA201406688B (https=)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2681215B1 (en) 2011-02-28 2015-04-22 Array Biopharma, Inc. Serine/threonine kinase inhibitors
US9187462B2 (en) 2011-08-04 2015-11-17 Array Biopharma Inc. Substituted quinazolines as serine/threonine kinase inhibitors
DK2820009T3 (en) * 2012-03-01 2018-04-16 Array Biopharma Inc Serine / threonine kinase inhibitors
EP2844652B1 (en) * 2012-05-03 2019-03-13 Genentech, Inc. Pyrazole aminopyrimidine derivatives as lrrk2 modulators
TW201408658A (zh) 2012-08-27 2014-03-01 Array Biopharma Inc 絲胺酸/酥胺酸激酶抑制劑
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
MX2015004615A (es) 2012-10-16 2015-07-17 Hoffmann La Roche Inhibidores de serina/treonina cinasa.
US9532987B2 (en) 2013-09-05 2017-01-03 Genentech, Inc. Use of a combination of a MEK inhibitor and an ERK inhibitor for treatment of hyperproliferative diseases
AP2016009099A0 (en) 2013-11-01 2016-03-31 Novartis Ag Aminoheteroaryl benzamides as kinase inhibitors
CN106029672B (zh) 2013-12-06 2019-03-29 基因泰克公司 丝氨酸/苏氨酸激酶抑制剂
BR112016015235A2 (pt) 2013-12-30 2017-08-08 Genentech Inc Composto, composição farmacêutica, método de inibição da atividade da proteína quinase erk e método de tratamento
JP6642942B2 (ja) * 2013-12-30 2020-02-12 アレイ バイオファーマ、インコーポレイテッド セリン/トレオニンキナーゼ阻害剤
MX382781B (es) 2014-04-02 2025-03-13 Intermune Inc Piridinonas anti-fibroticas.
EP3129025B1 (en) * 2014-04-09 2019-05-15 Genentech, Inc. Process for the manufacturing of medicaments
US9879029B2 (en) 2014-12-22 2018-01-30 Eli Lilly And Company ERK inhibitors
TWI704151B (zh) * 2014-12-22 2020-09-11 美商美國禮來大藥廠 Erk抑制劑
CN107849046B (zh) * 2015-06-03 2020-06-12 常州捷凯医药科技有限公司 作为erk抑制剂的杂环化合物
WO2016192064A1 (en) 2015-06-03 2016-12-08 Js Innopharm (Shanghai) Ltd. Heterocyclic compounds for treating psoriasis
HUE068392T2 (hu) 2015-10-21 2024-12-28 Otsuka Pharma Co Ltd Benzolaktám vegyületek mint fehérje kináz gátlók
US10208024B2 (en) 2015-10-23 2019-02-19 Array Biopharma Inc. 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases
LT3374359T (lt) 2015-11-09 2020-03-25 Astrazeneca Ab Dihidroimidazopirazinono deriniai, tinkami panaudoti vėžio gydymui
US11214565B2 (en) 2015-11-20 2022-01-04 Denali Therapeutics Inc. Compound, compositions, and methods
US11028080B2 (en) 2016-03-11 2021-06-08 Denali Therapeutics Inc. Substituted pyrimidines as LRKK2 inhibitors
KR20180134347A (ko) 2016-04-15 2018-12-18 제넨테크, 인크. 암의 진단 및 치료 방법
SMT202100699T1 (it) 2016-06-16 2022-01-10 Denali Therapeutics Inc Pirimidin-2-ilammino-1h-pirazoli come inibitori di lrrk2 per l'uso nel trattamento di disturbi neurodegenerativi
GB201706327D0 (en) 2017-04-20 2017-06-07 Otsuka Pharma Co Ltd A pharmaceutical compound
US11242334B2 (en) 2017-08-22 2022-02-08 Js Innopharm (Shanghai) Ltd. Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof
JP7199737B2 (ja) * 2017-08-23 2023-01-06 スプリント バイオサイエンス アクティエボラーグ ピリジルピリドン化合物
KR102811888B1 (ko) 2017-09-08 2025-05-27 에프. 호프만-라 로슈 아게 암의 진단 및 치료 방법
CU20200035A7 (es) 2017-11-24 2021-03-11 Novartis Ag Compuestos derivados de piridin-2-ona (6´-oxo-1´,6´dihidro) sustituidos como inhibidores selectivos de alk-2
JP7168149B2 (ja) * 2018-02-08 2022-11-09 ▲ザン▼州片仔▲ファン▼薬業股▲フン▼有限公司 Fgfr阻害剤としてのピラジン-2(1h)-オン系化合物
EP3752200A1 (en) 2018-02-13 2020-12-23 Vib Vzw Targeting minimal residual disease in cancer with rxr antagonists
US12133841B2 (en) 2018-05-22 2024-11-05 Js Innomed Holdings Ltd. Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof
US12351571B2 (en) 2018-12-19 2025-07-08 Array Biopharma Inc. Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinases
EP3898626A1 (en) 2018-12-19 2021-10-27 Array Biopharma, Inc. Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of fgfr tyrosine kinases
BR112021017957A2 (pt) * 2019-03-28 2021-11-23 Jiangsu Hengrui Medicine Co Derivado tienoeterocíclico, método de preparação do mesmo e uso médico do mesmo
WO2020228817A1 (zh) * 2019-05-15 2020-11-19 南京明德新药研发有限公司 Erk抑制剂及其应用
US20220235064A1 (en) 2019-08-02 2022-07-28 Wellmarker Bio Co., Ltd. Oxo-pyridine fusion ring derivative and pharmaceutical composition comprising same
WO2022100586A1 (zh) * 2020-11-11 2022-05-19 南京明德新药研发有限公司 一种含氧杂环丁烷的螺环类化合物的晶型、制备方法及其应用
CN115413669B (zh) * 2022-06-14 2024-03-15 湖南大学 激酶抑制剂及其组合剂在提高植物青枯病抗性中的应用
TW202529768A (zh) 2023-09-29 2025-08-01 大陸商德昇濟醫藥(無錫)有限公司 癌症治療的療法

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009847A1 (en) 1993-10-01 1995-04-13 Ciba-Geigy Ag Pyrimidineamine derivatives and processes for the preparation thereof
WO1995009851A1 (en) 1993-10-01 1995-04-13 Ciba-Geigy Ag Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof
US5543523A (en) 1994-11-15 1996-08-06 Regents Of The University Of Minnesota Method and intermediates for the synthesis of korupensamines
EP0948496A2 (en) 1996-12-05 1999-10-13 Amgen inc. Substituted pyrimidinone and pyridone compounds and methods of use
US6602872B1 (en) * 1999-12-13 2003-08-05 Merck & Co., Inc. Substituted pyridazines having cytokine inhibitory activity
WO2001062233A2 (en) 2000-02-25 2001-08-30 F. Hoffmann La Roche Ag Adenosine receptor modulators
AU5260601A (en) 2000-04-26 2001-11-07 Eisai Co Ltd Medicinal compositions promoting bowel movement
DE50104114D1 (de) 2000-05-02 2004-11-18 Tietze Lutz F Neue prodrugs von 6-hydroxy-2,3-dihydro-1h-indolen, 5-hydroxy-1,2-dihydro-3h-pyrrolo 3,2-e]indolen und 5-hydroxy-1,2-dihydro-3h-benzo e]indolen sowie von 6-hydroxy-1,2,3,4-tetrahydro-benzo f]chinolin-derivaten für eine selektive krebstherapie
WO2002088079A2 (en) 2001-05-01 2002-11-07 Bristol-Myers Squibb Company Dual inhibitors of pde 7 and pde 4
WO2003030909A1 (en) 2001-09-25 2003-04-17 Bayer Pharmaceuticals Corporation 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
TWI330183B (https=) * 2001-10-22 2010-09-11 Eisai R&D Man Co Ltd
WO2003057689A1 (en) * 2002-01-02 2003-07-17 Fujisawa Pharmaceutical Co., Ltd. Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them
ATE448784T1 (de) * 2002-02-14 2009-12-15 Pharmacia Corp Substituierte pyridinone als modulatoren für p38 map kinase
JP4606161B2 (ja) * 2002-05-21 2011-01-05 アムジエン・インコーポレーテツド 置換複素環式化合物および使用方法
GB0215676D0 (en) * 2002-07-05 2002-08-14 Novartis Ag Organic compounds
US7208498B2 (en) 2002-07-15 2007-04-24 Merck & Co., Inc. Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
US20050014753A1 (en) 2003-04-04 2005-01-20 Irm Llc Novel compounds and compositions as protein kinase inhibitors
CL2004002050A1 (es) * 2003-08-13 2005-06-03 Pharmacia Corp Sa Organizada B Compuestos derivados de piridinonas sustituidas; su uso en el tratamiento de afecciones causadas o exacerbadas por actividad p38 map kinasa y/o tnf no regulada, tales como inflamaciones, tumores, sida y otros.
TW200533357A (en) 2004-01-08 2005-10-16 Millennium Pharm Inc 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases
CA2561895A1 (en) 2004-04-13 2005-10-27 Icagen, Inc. Polycyclic pyrimidines as potassium ion channel modulators
US7429604B2 (en) * 2004-06-15 2008-09-30 Bristol Myers Squibb Company Six-membered heterocycles useful as serine protease inhibitors
JP2008510766A (ja) 2004-08-27 2008-04-10 ゲーペーツェー ビオテック アーゲー ピリミジン誘導体
GB0420722D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
GB0428514D0 (en) 2004-12-31 2005-02-09 Prosidion Ltd Compounds
TW200716594A (en) 2005-04-18 2007-05-01 Neurogen Corp Substituted heteroaryl CB1 antagonists
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7572809B2 (en) 2005-12-19 2009-08-11 Hoffmann-La Roche Inc. Isoquinoline aminopyrazole derivatives
JP2009528280A (ja) 2006-02-16 2009-08-06 シェーリング コーポレイション Erkインヒビターとしてのピロリジン誘導体
CA2651072A1 (en) 2006-05-01 2007-11-08 Pfizer Products Inc. Substituted 2-amino-fused heterocyclic compounds
DE102006035202A1 (de) 2006-07-29 2008-01-31 Lanxess Deutschland Gmbh Konservierungsmittel auf Basis von Carbonsäureanhydriden
CN101528729A (zh) 2006-08-23 2009-09-09 辉瑞产品公司 作为gsk-3抑制剂的嘧啶酮化合物
WO2008039882A1 (en) 2006-09-30 2008-04-03 Sanofi-Aventis U.S. Llc A combination of niacin and a prostaglandin d2 receptor antagonist
JO2985B1 (ar) 2006-12-20 2016-09-05 Takeda Pharmaceuticals Co مثبطات كينازmapk/erk
CN101568529A (zh) 2006-12-22 2009-10-28 诺瓦提斯公司 作为cdk抑制剂、用于治疗癌症、炎症和病毒感染的杂芳基-杂芳基化合物
AR065137A1 (es) 2007-02-01 2009-05-20 Tibotec Pharm Ltd Procesos e intermediarios para la preparacion de un inhibidor de proteasa macrociclico del vhc y metodos de obtencion de los mencionados intermediarios.
KR20100020454A (ko) 2007-06-08 2010-02-22 바이엘 크롭사이언스 소시에떼아노님 살진균제 헤테로사이클릴-피리미디닐-아미노 유도체
JP5611826B2 (ja) 2007-09-04 2014-10-22 ザ スクリプス リサーチ インスティテュート タンパク質キナーゼ阻害剤としての置換されたピリミジニル−アミン
AU2008324833A1 (en) 2007-11-06 2009-05-14 E. I. Du Pont De Nemours And Company Fungicidal heterocyclic amines
US8716483B2 (en) 2008-02-21 2014-05-06 Merck Sharp & Dohme Corp. Compounds that are ERK inhibitors
WO2009146034A2 (en) 2008-03-31 2009-12-03 Takeda Pharmaceutical Company Limited Mapk/erk kinase inhibitors and methods of use thereof
US9187426B2 (en) 2008-06-27 2015-11-17 Novartis Ag Organic compounds
NZ603525A (en) 2008-06-27 2015-02-27 Celgene Avilomics Res Inc Pyrimidine based compound and uses thereof
ES2548882T3 (es) * 2008-12-08 2015-10-21 Arena Pharmaceuticals, Inc. Moduladores del receptor de prostaciclina (PGl2) útiles para el tratamiento de trastornos relacionados con los mismos
DE102009051799B4 (de) 2009-11-03 2021-07-01 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Bifunktionale Prodrugs und Drugs
DE102009060175A1 (de) 2009-12-23 2011-06-30 Merck Patent GmbH, 64293 Pyrrolo[2,3-d] pyrazin-7-yl-pyrimidin-Verbindungen
WO2012020786A1 (ja) * 2010-08-11 2012-02-16 日本新薬株式会社 医薬組成物
EP2681215B1 (en) 2011-02-28 2015-04-22 Array Biopharma, Inc. Serine/threonine kinase inhibitors
CN102250065B (zh) * 2011-05-20 2015-05-13 浙江海正药业股份有限公司 取代的三嗪苯脲衍生物及其用途
US9187462B2 (en) 2011-08-04 2015-11-17 Array Biopharma Inc. Substituted quinazolines as serine/threonine kinase inhibitors
DK2820009T3 (en) 2012-03-01 2018-04-16 Array Biopharma Inc Serine / threonine kinase inhibitors
TW201408658A (zh) 2012-08-27 2014-03-01 Array Biopharma Inc 絲胺酸/酥胺酸激酶抑制劑
KR102244553B1 (ko) 2013-08-23 2021-04-23 가부시키가이샤 한도오따이 에네루기 켄큐쇼 용량 소자 및 반도체 장치
US9532987B2 (en) * 2013-09-05 2017-01-03 Genentech, Inc. Use of a combination of a MEK inhibitor and an ERK inhibitor for treatment of hyperproliferative diseases
BR112016015235A2 (pt) * 2013-12-30 2017-08-08 Genentech Inc Composto, composição farmacêutica, método de inibição da atividade da proteína quinase erk e método de tratamento
JP6642942B2 (ja) * 2013-12-30 2020-02-12 アレイ バイオファーマ、インコーポレイテッド セリン/トレオニンキナーゼ阻害剤
EP3129025B1 (en) * 2014-04-09 2019-05-15 Genentech, Inc. Process for the manufacturing of medicaments

Similar Documents

Publication Publication Date Title
JP2015508828A5 (https=)
HRP20210482T1 (hr) Inhibitori serinske/treoninske kinaze
JP7460593B2 (ja) サイクリン依存性キナーゼ7(cdk7)の阻害剤
JP2017500364A5 (https=)
AU2018201953A1 (en) Certain amino-pyridazines, compositions thereof, and methods of their use
JP2017502049A5 (https=)
KR20160106627A (ko) 치료적 억제 화합물
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
KR102082331B1 (ko) Cot 조정제로서의 6-아미노-퀴놀린-3-카르보니트릴
JP2013527173A5 (https=)
FI3356344T3 (fi) Mdm2-p53-vuorovaikutuksen isoindolinoniestäjiä, joilla on syövänvastaista aktiivisuutta
JP2016530299A5 (https=)
EP2763672A1 (en) 1,3-substituted azetidine pde10 inhibitors
JP2014528446A5 (https=)
RU2019117958A (ru) Производные индола, полезные в качестве ингибиторов диацилглицерид-о-ацилтрансферазы 2
WO2022165530A1 (en) Small molecule inhibitors of salt inducible kinases
KR101898364B1 (ko) 인돌린-2-온 및 1,3-다이하이드로-피롤로[3,2-c]피리딘-2-온 유도체
JP2018111688A (ja) 医薬組成物
JPWO2017007008A1 (ja) 新規イミド誘導体およびその医薬としての用途
RU2025103751A (ru) Соединения на основе имидазопиридина, их получение и варианты их терапевтического применения
RU2022107496A (ru) Производные гетероциклического пиразола как ингибиторы рецепторной тирозикиназы типа III
HK1254429B (en) Serine/threonine kinase inhibitors
HK1225735A1 (zh) 丝氨酸/苏氨酸激酶抑制剂
KR20130115470A (ko) 신규한 히드라진온이 치환된 피리미딘 유도체 및 그의 용도